Symrise Increases Equity for Diana Takeover

German flavors and fragrances manufacturer Symrise has increased its equity by around €400 million to finance its planned acquisition of French food ingredient maker Diana for €1.3 billion.

Diana is a leading supplier to the food, pet food, nutraceutical, aquaculture and cosmetics industries. Symrise said the buy would enable it to significantly expand its position in the flavour and nutrition markets and broaden its activities into the pet food markets.

In March, news agencies reported that Diana had also attracted Japan's Ajinomoto, along with private equity firms such as CVC Capital Partners , Euroazeo and Pamplona.

For 2013, the French group reported sales of around €425 million and an EBITDA margin of around 21%.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.